Curcumin nanoparticles show promise in treating neurodegenerative diseases

FHS
June 7, 2024
3:18 am

Review demonstrates curcumin’s neuroprotective effects in neurodegenerative diseases, enhancing its potential through innovative nanoparticle formulations. This advancement could significantly improve treatments for diseases like Parkinson’s, Alzheimer’s, and Multiple Sclerosis.

Headspace plans to be cash-flow positive in the first quarter of 2024

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) SAN FRANCISCO — Despite a $3 billion

January 26, 2024

HPV Vaccine Coverage in Teens Stalled for Second Straight Year, CDC Says

Human papillomavirus (HPV) vaccine coverage among teens remained stalled for a second consecutive year since the pandemic, CDC data showed. In 2023, 76.8% of adolescents

August 24, 2024

Epic Systems v. Particle: What the Carequality investigation reveals about the dispute

Late Tuesday night, Carequality released new information about its investigation into the dispute between electronic health records vendor Epic Systems and health data startup Particle

October 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.